The FDA has approved a device that aims to treat depression by sending electric current into a part of the brain known to ...
Patients can use the headset themselves in their homes to counteract moderate to severe depression, with what the FDA says ...
Flow Neuroscience announced that the FDA approved its Flow at-home brain stimulation device for treating major depressive ...
The U.S. Food and Drug Administration has approved Flow Neuroscience's at-home brain stimulation device to treat depression, ...
A new analysis shows that anti-inflammatory medications may help reduce symptoms for a subset of people with depression who ...
Medical Device Network on MSN
FDA clears Flow Neuroscience’s at-home depression treatment in US first
Flow Neuroscience’s at-home depression treatment device has become the first of its kind to be approved by the FDA.
Zurzuvae, the recently FDA-approved pill to treat postpartum depression. (Image: Getty; illustration by Alex Cochran for Yahoo) In August the Food and Drug Administration approved Zurzuvae (zuranolone ...
There's a well-established link between depression and chronic low-grade inflammation. Now, a new meta-study shows that ...
Health Canada has approved the first drug designed to treat postpartum depression. The regulator says zuranolone, a pill sold ...
Depression has been tied to a two-fold increased risk offor epilepsy and a suboptimal response to initial therapy, ...
A new study out of Stanford Medicine has found a “new category of depression” that impacts 27% of diagnosed individuals and is “not effectively” treated by standard antidepressants. Specifically, this ...
People with depression have a more than doubled risk of developing epilepsy, and the mental illness also makes epilepsy more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback